Obstetric and Neonatal Outcomes in Pregnancies From a Dedicated Cystic Fibrosis‐Maternal Health Service: A Retrospective Study
FwCF have improved maternal, obstetric and neonatal outcomes since the introduction of ETI-therapy, within a dedicated CF-Maternal Health service.
Authors
- Andrew Jones (ORCID: https://orcid.org/0000-0003-0471-6228)
- S. Collins
- Natasha Singh (ORCID: https://orcid.org/0000-0002-5130-9679)
- Rebecca Scott (ORCID: https://orcid.org/0000-0002-8709-3494)
- I. Felton
- Rachel Robinson (ORCID: https://orcid.org/0000-0002-3092-1308)
- Nicholas J. Simmonds (ORCID: https://orcid.org/0000-0002-1705-4780)
- Emily Diable
- Thomas Tobin (ORCID: https://orcid.org/0000-0003-0992-7809)
- Rebecca Dobra (ORCID: https://orcid.org/0000-0002-6857-0988)
- L. Weitnauer
- A. Downes
- Elaine Bowman
Institutions
- Cystic Fibrosis Trust (GB)
- Royal Brompton Hospital (GB)
- Chelsea and Westminster Hospital (GB)
- Imperial College London (GB)
Publication Details
- Journal
- BJOG An International Journal of Obstetrics & Gynaecology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1111/1471-0528.70075
- Citations
- 2
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 3.04